HAYWARD, Calif. & FORT DODGE, Iowa--(BUSINESS WIRE)--Lygos, a sustainable specialty chemical company, announced today the signing of an MOU agreement with global fermentation and biotechnology leader, ...

MOUNTAIN VIEW, CA / ACCESS Newswire / January 8, 2026 / AbTherx today announced a therapeutic antibody discovery and development partnership with Red Queen Bio, combining AbTherx's Atlas ™ Full Human ...

Gator will integrate one of Monod's AI-designed NovoBody™ binding proteins into its industry-leading biolayer interferometry platform NovoBody™ binding proteins deliver superior performance, stability ...

Oncology-focused digital health company Flatiron Health announced it entered into a strategic partnership with Massive Bio, a company that helps cancer patients find and enroll in clinical trials.

NEW YORK--(BUSINESS WIRE)--Massive Bio, a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. today announced a strategic collaboration to increase patient ...

Cellino, a biotechnology firm working on autonomous biomanufacturing for personalized regenerative medicines, has signed a strategic collaboration with Karis Bio, a South Korean cell therapy company, ...

RADNOR, PA & PHILADELPHIA, PA — Avantor, Inc. (NYSE: AVTR) has entered into a strategic partnership with BlueWhale Bio, a commercial-stage biotechnology firm focused on improving immune cell therapy ...

The Ginkgo Technology Network brings together over 25 diverse partners across an array of capabilities including AI, genetic medicines, biologics, and manufacturing. As a Ginkgo Technology Network ...

Collaboration with intent to validate Cellares’ Cell Shuttle platform for manufacturing of CABA-201, Cabaletta Bio’s fully human CD19-CAR T product candidate, which is being evaluated in parallel ...

Passage Bio, a developer of gene therapies for rare monogenic CNS diseases launched five months ago, will partner with Catalent’s Paragon Gene Therapy unit to develop a dedicated manufacturing suite ...

"Red Queen Bio is extremely excited to begin this journey with AbTherx as our partner for in vivo binder discovery," said Nikolai Eroshenko, CEO of Red Queen Bio. "We believe AbTherx's ...